1. Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child‐Pugh B cirrhosis. (2nd June 2022) Authors: Chapin, William J.; Hwang, Wei‐Ting; Karasic, Thomas B.; McCarthy, Anne Marie; Kaplan, David E. Journal: Cancer medicine Issue: Volume 12:Number 1(2023) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2. Issue 22 (1st August 2021) Authors: Reiss, Kim A.; Mick, Rosemarie; O'Hara, Mark H.; Teitelbaum, Ursina; Karasic, Thomas B.; Schneider, Charles; Cowden, Stacy; Southwell, Traci; Romeo, Janae; Izgur, Natallia; Hannan, Zain M.; Tondon, Rashmi; Nathanson, Katherine; Vonderheide, Robert H.; Wattenberg, Max M.; Beatty, Gregory; Domchek,... Journal: Journal of clinical oncology Issue: Volume 39:Issue 22(2021) Page Start: 2497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer. (20th January 2021) Authors: Dreyfuss, Alexandra D.; Barsky, Andrew R.; Wileyto, E. Paul; Eads, Jennifer R.; Kucharczuk, John C.; Williams, Noel N.; Karasic, Thomas B.; Metz, James M.; Ben‐Josef, Edgar; Plastaras, John P.; Wojcieszynski, Andrzej P. Journal: Cancer medicine Issue: Volume 10:Number 4(2021) Page Start: 1275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗